Hyperlipidemia Type 3 Overview

Save information for later
Sign Up

Learn About Hyperlipidemia Type 3

What is the definition of Hyperlipidemia Type 3?
Hyperlipidemia type 3 is an inherited condition that disrupts the normal breakdown of fats (lipids) in the body, causing a large amount of certain fatty materials to build up in the body. Some individuals never have symptoms of this condition. Symptoms usually do not appear unless a second genetic or environmental factor adds to increased lipid levels. Symptoms may include: yellowish lipid-filled bumps on the skin (xanthomas), inflammation of the pancreas (pancreatitis), and a buildup of fat in the blood vessels (atherosclerosis). Hyperlipidemia type 3 may lead to the development of cardiovascular disease. This condition is caused by genetic changes in the APOE gene. The inheritance of this condition is considered to be complicated, as having genetic changes in the APOE gene often does not lead to the development of symptoms without the influence of other factors. Most people with symptoms of Hyperlipidemia type 3 have two genetic changes in the APOE gene, inherited in an autosomal recessive manner.
What are the alternative names for Hyperlipidemia Type 3?
  • Hyperlipidemia type 3
  • Broad beta disease
  • Broad-betalipoproteinemia
  • Familial dysbetalipoproteinemia
  • Hyperlipoproteinemia type 3
  • Hyperlipoproteinemia type III
  • Remnant removal disease
Who are the top Hyperlipidemia Type 3 Local Doctors?
Experienced in Hyperlipidemia Type 3
Dr. Thomas K. Jones
Internal Medicine
Experienced in Hyperlipidemia Type 3
Dr. Thomas K. Jones
Internal Medicine

Ihc Health Services Inc

577 S River Rd, 
St George, UT 
 (0.7 mi)
435-688-6200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thomas Jones is an Internal Medicine provider in St George, Utah. Dr. Jones and is rated as an Experienced provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Osteomyelitis in Children, Type 2 Diabetes (T2D), Tietz Syndrome, and Endoscopy. Dr. Jones is currently accepting new patients.

Experienced in Hyperlipidemia Type 3
Dr. Tyler H. Haberle
Internal Medicine
Experienced in Hyperlipidemia Type 3
Dr. Tyler H. Haberle
Internal Medicine

Ihc Health Services Inc

577 S River Rd, 
St George, UT 
 (0.7 mi)
435-688-6000
Languages Spoken:
English, Portuguese, Spanish
See accepted insurances

Tyler Haberle is an Internal Medicine provider in St George, Utah. Dr. Haberle and is rated as an Experienced provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Hyperlipidemia Type 3
Dr. J S. Parkinson
Internal Medicine
Experienced in Hyperlipidemia Type 3
Dr. J S. Parkinson
Internal Medicine

Ihc Health Services Inc

577 S River Rd, 
St George, UT 
 (0.7 mi)
435-688-6200
Languages Spoken:
English, Swedish
See accepted insurances
Accepting New Patients
Offers Telehealth

J Parkinson is an Internal Medicine provider in St George, Utah. Dr. Parkinson and is rated as an Experienced provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Osteomyelitis in Children, Bacterial Meningitis, Type 2 Diabetes (T2D), and Vertigo. Dr. Parkinson is currently accepting new patients.

View All Doctors
What are the latest Hyperlipidemia Type 3 Clinical Trials?
The Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) Study
The Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) Study
Enrollment Status: Recruiting
Publish Date: May 16, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable

Summary: ACCURATE will test the hypothesis that opportunistic genetic testing for Familial Hypercholesterolemia (FH) in patients admitted to hospital with an acute coronary syndrome will increase the diagnosis of FH and will impact patient care and outcomes. The study will recruit patients admitted to hospital with an acute coronary syndrome, and research-based genetic testing will be conducted for known F...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center